2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 8.952 | 13.580 | 18.959 | 12.739 | 63.293 | 19.072 | 5.913 | 558 | 110.047 | 13.141 |
Total Income - EUR | 12.392 | 17.739 | 19.392 | 12.950 | 63.530 | 19.356 | 6.098 | 680 | 109.771 | 36.656 |
Total Expenses - EUR | 12.002 | 16.680 | 17.645 | 12.646 | 62.596 | 18.116 | 5.086 | 4.098 | 107.680 | 62.462 |
Gross Profit/Loss - EUR | 390 | 1.059 | 1.747 | 303 | 934 | 1.240 | 1.012 | -3.418 | 2.091 | -25.807 |
Net Profit/Loss - EUR | 36 | 534 | 1.368 | 175 | 286 | 664 | 848 | -3.436 | 1.109 | -25.938 |
Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 0 | 1 | 2 |
Check the financial reports for the company - Nutraceutical S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.283 | 2.131 | 1.697 | 1.376 | 951 | 540 | 210 | 0 | 0 | 5.676 |
Current Assets | 32.998 | 34.578 | 36.024 | 38.825 | 49.293 | 38.413 | 37.238 | 34.207 | 77.544 | 93.750 |
Inventories | 9.065 | 9.123 | 9.030 | 8.877 | 8.968 | 8.500 | 8.339 | 8.154 | 8.179 | 183 |
Receivables | 23.645 | 21.172 | 26.730 | 28.929 | 32.198 | 27.834 | 26.882 | 25.936 | 62.526 | 85.641 |
Cash | 288 | 4.282 | 264 | 1.019 | 8.127 | 2.079 | 2.017 | 117 | 6.838 | 7.925 |
Shareholders Funds | 9.858 | 10.474 | 11.735 | 11.711 | 11.782 | 12.218 | 12.834 | 9.114 | 10.251 | -15.718 |
Social Capital | 112 | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 |
Debts | 24.423 | 26.294 | 25.986 | 28.490 | 38.462 | 26.735 | 24.614 | 25.093 | 37.906 | 54.253 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29.387 | 60.891 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "1089 - 1089" | |||||||||
CAEN Financial Year |
1089
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Nutraceutical S.r.l.